Your browser is no longer supported. Please, upgrade your browser.
JanOne Inc.
Index- P/E- EPS (ttm)-3.88 Insider Own29.26% Shs Outstand2.40M Perf Week0.32%
Market Cap15.39M Forward P/E- EPS next Y- Insider Trans-4.44% Shs Float1.88M Perf Month-1.85%
Income-8.30M PEG- EPS next Q- Inst Own21.50% Short Float14.52% Perf Quarter-27.73%
Sales38.70M P/S0.40 EPS this Y32.40% Inst Trans9.24% Short Ratio1.01 Perf Half Y-19.39%
Book/sh1.50 P/B4.24 EPS next Y- ROA-31.40% Target Price4.00 Perf Year39.17%
Cash/sh1.53 P/C4.16 EPS next 5Y- ROE-167.30% 52W Range3.49 - 31.83 Perf YTD30.06%
Dividend- P/FCF- EPS past 5Y-14.50% ROI-127.40% 52W High-80.02% Beta1.62
Dividend %- Quick Ratio0.40 Sales past 5Y-21.30% Gross Margin24.50% 52W Low82.23% ATR0.42
Employees154 Current Ratio0.50 Sales Q/Q115.00% Oper. Margin-20.40% RSI (14)45.87 Volatility6.22% 6.81%
OptionableNo Debt/Eq0.75 EPS Q/Q-69.00% Profit Margin-21.30% Rel Volume0.18 Prev Close6.20
ShortableYes LT Debt/Eq0.39 Earnings- Payout- Avg Volume270.32K Price6.36
Recom- SMA20-3.72% SMA50-7.29% SMA200-11.47% Volume49,021 Change2.58%
Jul-22-21 09:45AM  
Jun-23-21 10:10AM  
Jun-22-21 09:46AM  
Jun-15-21 10:15AM  
Jun-10-21 10:15AM  
Jun-08-21 09:45AM  
Feb-25-21 09:29AM  
Feb-02-21 11:45AM  
Jan-29-21 08:45AM  
Sep-24-20 10:45AM  
Sep-22-20 09:45AM  
Sep-16-20 02:37PM  
Sep-03-20 10:30AM  
Aug-31-20 05:00PM  
Aug-28-20 02:34PM  
Aug-26-20 09:45AM  
Aug-21-20 10:31AM  
Aug-19-20 02:50PM  
Aug-11-20 07:00PM  
Aug-06-20 02:30PM  
Aug-04-20 09:47AM  
Jul-30-20 09:30AM  
Jul-21-20 09:25AM  
Jul-08-20 09:30AM  
Jun-30-20 09:30AM  
Jun-25-20 02:23PM  
Jun-18-20 09:27AM  
Feb-06-20 09:02AM  
Jan-28-20 09:02AM  
Jan-23-20 09:02AM  
Jan-16-20 10:51AM  
Dec-03-19 09:03AM  
Nov-25-19 09:00AM  
Sep-12-19 08:00AM  
Sep-11-19 08:03AM  
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain. It operates in three segments: Biotechnology, Recycling, and Technology. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. It also provides turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs; and designs, develops, and sells cellular transceiver modules and associated wireless services. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Johnson Virland AChief Financial OfficerMay 24Sale6.7032,933220,6510May 26 04:02 PM
Johnson Virland AChief Financial OfficerFeb 05Sale8.654,11235,56932,933Feb 11 10:58 AM
Johnson Virland AChief Financial OfficerNov 03Sale3.611,4695,30337,045Feb 11 10:58 AM